Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-18-054992
Filing Date
2018-10-23
Accepted
2018-10-23 17:10:29
Documents
1
Period of Report
2018-10-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv505271_form4.html 4  
1 OWNERSHIP DOCUMENT tv505271_form4.xml 4 4219
  Complete submission text file 0001144204-18-054992.txt   5947
Mailing Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202
Business Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202 (904) 516-5436
Marker Therapeutics, Inc. (Issuer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 50 NORTH LAURA STREET SUITE 2500 JACKSONVILLE FL 32202
Business Address 904-257-8704
Loiacono Michael (Reporting) CIK: 0001679119 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37939 | Film No.: 181134686